Alex is a Vice President at Locust Walk, where he brings expertise in life sciences transactions and strategic advisory services. At the firm, Alex has executed a wide range of strategic transactions and private capital raises, working with companies of all sizes and stages of development across diverse therapeutic areas. He brings leadership in transaction strategy, corporate development, and new company creation initiatives. Additionally, Alex plays a pivotal role on the firm’s internal scientific due diligence committee, contributing his analytical and strategic insights to evaluate potential opportunities.

Before joining Locust Walk, Alex was a consultant at ClearView Healthcare Partners, where he specialized in biopharma strategy, market analysis, and clinical development. His work focused on delivering impactful solutions to clients with a focus on new product planning and commercial due diligence, helping clients navigate complex market landscapes and make data-driven strategic decisions.

Alex holds a B.A. in Neuroscience from Middlebury College. He is a FINRA registered representative with Series 79 and 63 licenses.